MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
MRTX
Delisted
MRTX was delisted on the 22nd of January, 2024.
221 hedge funds and large institutions have $2.38B invested in Mirati Therapeutics, Inc. Common Stock in 2023 Q1 according to their latest regulatory filings, with 31 funds opening new positions, 88 increasing their positions, 65 reducing their positions, and 41 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
24% less first-time investments, than exits
New positions opened: 31 | Existing positions closed: 41
30% less funds holding in top 10
Funds holding in top 10: 10 → 7 (-3)
Holders
221
Holding in Top 10
7
Calls
$16.7M
Puts
$10.6M
Top Buyers
| 1 | +$21.3M | |
| 2 | +$20.5M | |
| 3 | +$19.5M | |
| 4 |
Morgan Stanley
New York
|
+$13.4M |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$13.2M |
Top Sellers
| 1 | -$28.9M | |
| 2 | -$23M | |
| 3 | -$21.7M | |
| 4 |
Janus Henderson Group
London,
United Kingdom
|
-$18.9M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
-$18.9M |